$ALNY News Article - Alnylam Announces Receipt of Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
https://marketwirenews.com/news-releases/alny...81172.html